Related Experiment Videos
Autoimmune Pancreatitis
Shounak Majumder1, Naoki Takahashi2, Suresh T Chari3
1Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Digestive Diseases and Sciences
|April 3, 2017
Summary
Autoimmune pancreatitis (AIP) and idiopathic duct-centric pancreatitis (IDCP) are distinct IgG4-related diseases. While both share some features, IDCP presents differently and has a lower relapse rate, aiding in diagnosis and treatment strategies.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Autoimmune pancreatitis (AIP) is a chronic fibroinflammatory pancreatic disease within the immunoglobulin G4-related disease (IgG4-RD) spectrum.
- Idiopathic duct-centric pancreatitis (IDCP) mimics AIP radiologically but presents clinically as recurrent acute pancreatitis, often with inflammatory bowel disease.
- Distinguishing AIP from IDCP is crucial due to differences in IgG4 levels, histology, and natural history.
Purpose of the Study:
- To delineate the key differences between autoimmune pancreatitis (AIP) and idiopathic duct-centric pancreatitis (IDCP).
- To highlight diagnostic features, including serological and histological findings.
- To compare the clinical presentation, treatment response, and relapse rates of AIP and IDCP.
Main Methods:
- Comparative analysis of clinical presentations, radiological findings, and laboratory data (including IgG4 levels).
- Histopathological examination focusing on lymphoplasmacytic inflammation, fibrosis, and the characteristic granulocyte epithelial lesion in IDCP.
- Review of treatment protocols, including corticosteroid use and outcomes for relapsing cases.
Main Results:
- AIP typically presents with obstructive jaundice and elevated IgG4 levels, while IDCP commonly manifests as recurrent acute pancreatitis in patients with IBD and normal IgG4 levels.
- Histology reveals lymphoplasmacytic inflammation and fibrosis in both, but IDCP is uniquely characterized by granulocyte epithelial lesions in ducts.
- Initial corticosteroid treatment is similar, but relapses are more frequent in AIP than in IDCP.
Conclusions:
- AIP and IDCP are distinct entities within the IgG4-RD spectrum, differentiated by clinical presentation, IgG4 levels, and specific histological features.
- The granulocyte epithelial lesion is a key diagnostic hallmark of IDCP.
- While relapsing AIP may require immunomodulators or rituximab, IDCP appears to have a more favorable prognosis with less frequent relapses.